<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64653</article-id><article-id pub-id-type="doi">10.7554/eLife.64653</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-213940"><name><surname>Barone</surname><given-names>Sierra M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5944-750X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213941"><name><surname>Paul</surname><given-names>Alberta GA</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-213942"><name><surname>Muehling</surname><given-names>Lyndsey M</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213943"><name><surname>Lannigan</surname><given-names>Joanne A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-213944"><name><surname>Kwok</surname><given-names>William W</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213945"><name><surname>Turner</surname><given-names>Ronald B</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213946"><name><surname>Woodfolk</surname><given-names>Judith A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-166931"><name><surname>Irish</surname><given-names>Jonathan M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9428-8866</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf4"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cell and Developmental Biology; Vanderbilt-Ingram Cancer Center,</institution>, <institution>Vanderbilt University</institution>, <addr-line><named-content content-type="city">Nashville</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Allergy Division</institution>, <institution>University of Virginia School of Medicine</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Allergy Division; Department of Microbiology, Immunology, and Cancer Biology</institution>, <institution>University of Virginia School of Medicine</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Microbiology, Immunology, and Cancer Biology</institution>, <institution>University of Virginia School of Medicine</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">N/A</institution>, <institution>Benaroya Research Institute at Virginia Mason</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Pediatrics</institution>, <institution>University of Virginia School of Medicine</institution>, <addr-line><named-content content-type="city">Charlottesville</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Department of Cell and Developmental Biology; Vanderbilt-Ingram Cancer Center; Department of Pathology, Microbiology and Immunology</institution>, <institution>Vanderbilt University</institution>, <addr-line><named-content content-type="city">Nashville</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-8404"><name><surname>Altan-Bonnet</surname><given-names>Grégoire</given-names></name><role>Reviewing editor</role><aff><institution>Memorial Sloan-Kettering Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jonathan.irish@vanderbilt.edu</email> (JI);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>08</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e64653</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>08</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Barone et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Barone et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64653-v1.pdf"/><abstract><p>For an emerging disease like COVID-19, systems immunology tools may quickly identify and quantitatively characterize cells associated with disease progression or clinical response. With repeated sampling, immune monitoring creates a real-time portrait of the cells reacting to a novel virus before disease specific knowledge and tools are established. However, single cell analysis tools can struggle to reveal rare cells that are under 0.1% of the population. Here, the machine learning workflow Tracking Responders Expanding (T-REX) was created to identify changes in both very rare and common cells in diverse human immune monitoring settings. T-REX identified cells that were highly similar in phenotype and localized to hotspots of significant change during rhinovirus and SARS-CoV-2 infections. Specialized reagents used to detect the rhinovirus-specific CD4<sup>+</sup> cells, MHCII tetramers, were not used during unsupervised analysis and instead 'left out' to serve as a test of whether T-REX identified biologically significant cells. In the rhinovirus challenge study, T-REX identified virus-specific CD4<sup>+</sup> T cells based on these cells being a distinct phenotype that expanded by ≥95% following infection. T-REX successfully identified hotspots containing virus-specific T cells using pairs of samples comparing Day 7 of infection to samples taken either prior to infection (Day 0) or after clearing the infection (Day 28). Mapping pairwise comparisons in samples according to both the direction and degree of change provided a framework to compare systems level immune changes during infectious disease or therapy response. This revealed that the magnitude and direction of systemic immune change in some COVID-19 patients was comparable to that of blast crisis acute myeloid leukemia patients undergoing induction chemotherapy and characterized the identity of the immune cells that changed the most. Other COVID-19 patients instead matched an immune trajectory like that of individuals with rhinovirus infection or melanoma patients receiving checkpoint inhibitor therapy. T-REX analysis of paired blood samples provides an approach to rapidly identify and characterize mechanistically significant cells and to place emerging diseases into a systems immunology context.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U01 AI125056</award-id><principal-award-recipient><name><surname>Barone</surname><given-names>Sierra M</given-names></name><name><surname>Paul</surname><given-names>Alberta GA</given-names></name><name><surname>Muehling</surname><given-names>Lyndsey M</given-names></name><name><surname>Turner</surname><given-names>Ronald B</given-names></name><name><surname>Woodfolk</surname><given-names>Judith A</given-names></name><name><surname>Irish</surname><given-names>Jonathan M</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01 CA226833</award-id><principal-award-recipient><name><surname>Barone</surname><given-names>Sierra M</given-names></name><name><surname>Irish</surname><given-names>Jonathan M</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>U54 CA217450</award-id><principal-award-recipient><name><surname>Irish</surname><given-names>Jonathan M</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>T32 AI007496</award-id><principal-award-recipient><name><surname>Muehling</surname><given-names>Lyndsey M</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007208</institution-id><institution>Vanderbilt-Ingram Cancer Center</institution></institution-wrap></funding-source><award-id>P30 CA68485</award-id><principal-award-recipient><name><surname>Barone</surname><given-names>Sierra M</given-names></name><name><surname>Irish</surname><given-names>Jonathan M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Alberta GA Paul, became an employee of Cytek Biosciences, Inc. after performing this research at University of Virginia..</p></fn><fn fn-type="conflict" id="conf3"><p>Joanne A Lannigan, became a paid consultant of Cytek Biosciences, Inc. after performing this research at University of Virginia..</p></fn><fn fn-type="conflict" id="conf4"><p>Jonathan M Irish, was a co-founder and a board member of Cytobank Inc. and received unrelated research support from Incyte Corp, Janssen, and Pharmacyclics..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Dataset 1 was a newly generated dataset of PBMCs obtained by longitudinal sampling of healthy volunteers who were challenged intranasally with RV-A16. The study was approved by the University of Virginia Human Investigations Committee, performed in accordance with the Declaration of Helsinki, and registered with ClinicalTrials.gov (NCT02796001). Informed consent was obtained from all study participants.  Data were collected and processed at the University of Virginia.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Datasets analyzed in this manuscript are available online, including at FlowRepository. COVID-19 Dataset 2 (https://ki.app.box.com/s/sby0jesyu23a65cbgv51vpbzqjdmipr1), melanoma Dataset 3 (https://flowrepository.org/id/FR-FCM-ZYDG), and AML Dataset 4 (https://flowrepository.org/id/FR-FCM-ZZMC) were described and shared online in the associated manuscripts. Rhinovirus Dataset 1 is a newly generated dataset created at the University of Virginia available on FlowRepository (FR-FCM-Z2VX available at: https://flowrepository.org/id/FR-FCM-Z2VX). Transparent analysis scripts for all four datasets and all presented results are publicly available on the CytoLab Github page for T-REX (https://github.com/cytolab/T-REX) and include open source code and commented Rmarkdown analysis walkthroughs.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Barone SM et al</collab></person-group><year iso-8601-date="2020">2020</year><source>Rhinovirus data from: Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy</source><ext-link ext-link-type="uri" xlink:href="https://flowrepository.org/id/FR-FCM-Z2VX">https://flowrepository.org/id/FR-FCM-Z2VX</ext-link><comment>FlowRepository FR-FCM-Z2VX</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Rodriguez L et al.</collab></person-group><year iso-8601-date="2020">2020</year><source>COVID-19 data from: Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19</source><ext-link ext-link-type="uri" xlink:href="https://ki.app.box.com/s/sby0jesyu23a65cbgv51vpbzqjdmipr1">https://ki.app.box.com/s/sby0jesyu23a65cbgv51vpbzqjdmipr1</ext-link><comment>COVID-19_project Brodin lab</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Greenplate AR et al.</collab></person-group><year iso-8601-date="2016">2016</year><source>Melanoma data from: Mass Cytometry of Peripheral Blood from Melanoma Patients Receiving anti-PD-1</source><ext-link ext-link-type="uri" xlink:href="http://flowrepository.org/id/FR-FCM-ZYDG">http://flowrepository.org/id/FR-FCM-ZYDG</ext-link><comment>FlowRepository FR-FCM-ZYDG</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ferrell PB Jr et al.</collab></person-group><year iso-8601-date="2016">2016</year><source>AML data from: High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic 684 Changes in Persistent Cells during Induction Therapy</source><ext-link ext-link-type="uri" xlink:href="http://flowrepository.org/id/FR-FCM-ZZMC">http://flowrepository.org/id/FR-FCM-ZZMC</ext-link><comment>FlowRepository FR-FCM-ZZMC</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-64653-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>